This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Yanay Ofran, Ph.D.
Chief Executive Officer at Biolojic Design


Prof. Ofran is a scientist, entrepreneur and a biotech executive. He received his PhD with distinction from the Dept. of Molecular Biophysics at Columbia University in NYC and became a world leader in the study of biomolecular recognition. Prof Ofran is the author of more than 100 papers and patents. He is the founder and CEO of Biolojic Design, a leading company in AI-based design of antibodies. He is also the co-founder and chairman of the board of Ukko and a co-founder and CSO of Aulos Biosciencer.

Agenda Sessions

  • Designing Clinical Antibodies with New Capabilities: Conditional Agonist/Antagonists, Logic Gates and Functional Switches